ΔΎΉΟΦ±²₯

Meeting Coverage

ASCO Video Pearls: NSCLC

Video Pearls from the American Society of Clinical Oncology

TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer

Phase II data show a manageable safety profile and encouraging anti-tumor activity

image

Latest ASCO Video Pearls: NSCLC Meeting Coverage

Novel TKI Promising in Early Study of HER2-Mutant NSCLC

Nicolas Girard, MD, PhD, explains the SOHO-01 study

June 28, 2024
Subcutaneous Amivantamab Could Offer a Patient-Centered Approach to NSCLC Treatment

"It really does appear to be superior in most ways," says Jorge Nieva, MD

June 21, 2024
Osimertinib Plus SABR Appears Safe, Effective for Advanced EGFR-Mutant NSCLC

The addition of SABR appears to provide PFS, OS benefit when considered against historical data

June 14, 2024
MYLUNG Consortium Finds Molecular Testing Gaps in NSCLC

With a growing number of relevant markers, testing rates remain tragically low, Jack West says

July 2, 2021
Is Disease-Free Survival a Meaningful Endpoint in NSCLC?

Nicholas Rohs believes IMpower010 is "definitely an impactful study"

June 25, 2021

Latest Oncology/Hematology Meeting Coverage